The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. [electronic resource]
- Journal of perinatal medicine 1995
- 83-8 p. digital
Publication Type: Clinical Trial; Journal Article
0300-5577
10.1515/jpme.1995.23.1-2.83 doi
Anemia--blood Erythrocytes--pathology Erythropoietin--therapeutic use Humans Iron--administration & dosage Kidney Failure, Chronic--complications Recombinant Proteins--therapeutic use Renal Dialysis